Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial
Titel:
Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial
Auteur:
Al-Sawaf, Othman Zhang, Can Tandon, Maneesh Sinha, Arijit Fink, Anna-Maria Robrecht, Sandra Samoylova, Olga Liberati, Anna M Pinilla-Ibarz, Javier Opat, Stephen Sivcheva, Liliya Le Dû, Katell Fogliatto, Laura M Niemann, Carsten U Weinkove, Robert Robinson, Sue Kipps, Thomas J Tausch, Eugen Schary, William Ritgen, Matthias Wendtner, Clemens-Martin Kreuzer, Karl-Anton Eichhorst, Barbara Stilgenbauer, Stephan Hallek, Michael Fischer, Kirsten